Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony P Ford

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Clinical Pharmacology in Drug Development|May 5, 2022
Clinical Formulation Bridging of Gefapixant, a P2X3-Receptor Antagonist, for the Treatment of Chronic CoughPranav Gupta, Azher Hussain, Anthony P Ford, et al.
Autonomic Neuroscience : Basic & Clinical|May 16, 2021
The inevitability of ATP as a transmitter in the carotid bodyEmma N Bardsley, Dylan K Pen, Fiona D McBryde, et al.
Lancet (London, England)|July 22, 2015
P2X3 receptor antagonist in chronic cough--Authors' replyJaclyn A Smith, Rayid Abdulqawi, Rachel Dockry, et al.
Frontiers in Molecular Biosciences|September 4, 2023
Fingerprinting heterocellular β-adrenoceptor functional expression in the brain using agonist activity profilesRachel A Matt, Frederick G Westhorpe, Rosemary F Romuar, et al.
Autonomic Neuroscience : Basic & Clinical|May 10, 2015
P2X3 receptors and sensitization of autonomic reflexesAnthony P Ford, Bradley J Undem, Lori A Birder, et al.
Lancet (London, England)|December 4, 2014
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 studyRayid Abdulqawi, Rachel Dockry, Kimberley Holt, et al.
Handbook of Experimental Pharmacology|July 26, 2023
Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative DiseaseRachel A Matt, Renee S Martin, Andrew K Evans, et al.
The Journal of Physiology|December 20, 2014
Postsynaptic P2X3-containing receptors in gustatory nerve fibres mediate responses to all taste qualities in miceAurelie Vandenbeuch, Eric D Larson, Catherine B Anderson, et al.
Pulmonary Therapy|June 21, 2021
Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical TrialFernando J Martinez, Amna Sadaf Afzal, Jaclyn A Smith, et al.
Respiratory Physiology & Neurobiology|April 8, 2020
P2X3 receptor antagonism reduces the occurrence of apnoeas in newborn ratsPedro Lourenço Katayama, Ana Paula Abdala, Ian Charles, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinical Pharmacology in Drug Development|May 5, 2022
Clinical Formulation Bridging of Gefapixant, a P2X3-Receptor Antagonist, for the Treatment of Chronic CoughPranav Gupta, Azher Hussain, Anthony P Ford, et al.
Autonomic Neuroscience : Basic & Clinical|May 16, 2021
The inevitability of ATP as a transmitter in the carotid bodyEmma N Bardsley, Dylan K Pen, Fiona D McBryde, et al.
Lancet (London, England)|July 22, 2015
P2X3 receptor antagonist in chronic cough--Authors' replyJaclyn A Smith, Rayid Abdulqawi, Rachel Dockry, et al.
Frontiers in Molecular Biosciences|September 4, 2023
Fingerprinting heterocellular β-adrenoceptor functional expression in the brain using agonist activity profilesRachel A Matt, Frederick G Westhorpe, Rosemary F Romuar, et al.
Autonomic Neuroscience : Basic & Clinical|May 10, 2015
P2X3 receptors and sensitization of autonomic reflexesAnthony P Ford, Bradley J Undem, Lori A Birder, et al.
Lancet (London, England)|December 4, 2014
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 studyRayid Abdulqawi, Rachel Dockry, Kimberley Holt, et al.
Handbook of Experimental Pharmacology|July 26, 2023
Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative DiseaseRachel A Matt, Renee S Martin, Andrew K Evans, et al.
The Journal of Physiology|December 20, 2014
Postsynaptic P2X3-containing receptors in gustatory nerve fibres mediate responses to all taste qualities in miceAurelie Vandenbeuch, Eric D Larson, Catherine B Anderson, et al.
Pulmonary Therapy|June 21, 2021
Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical TrialFernando J Martinez, Amna Sadaf Afzal, Jaclyn A Smith, et al.
Respiratory Physiology & Neurobiology|April 8, 2020
P2X3 receptor antagonism reduces the occurrence of apnoeas in newborn ratsPedro Lourenço Katayama, Ana Paula Abdala, Ian Charles, et al.
Pageof 4